| 000 | 01749 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516092055.0 | ||
| 264 | 0 | _c20120910 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0036476 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHysek, Cédric M | |
| 245 | 0 | 0 |
_aDuloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study. _h[electronic resource] |
| 260 |
_bPloS one _c2012 |
||
| 300 |
_ae36476 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a3,4-Methylenedioxyamphetamine _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiological Transport _xdrug effects |
| 650 | 0 | 4 | _aDuloxetine Hydrochloride |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLaboratories |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aN-Methyl-3,4-methylenedioxyamphetamine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
| 650 | 0 | 4 | _aPlacebo Effect |
| 650 | 0 | 4 |
_aReceptors, Adrenergic _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin Plasma Membrane Transport Proteins _xmetabolism |
| 650 | 0 | 4 |
_aThiophenes _xadverse effects |
| 700 | 1 | _aSimmler, Linda D | |
| 700 | 1 | _aNicola, Valentina G | |
| 700 | 1 | _aVischer, Nerina | |
| 700 | 1 | _aDonzelli, Massimiliano | |
| 700 | 1 | _aKrähenbühl, Stephan | |
| 700 | 1 | _aGrouzmann, Eric | |
| 700 | 1 | _aHuwyler, Jörg | |
| 700 | 1 | _aHoener, Marius C | |
| 700 | 1 | _aLiechti, Matthias E | |
| 773 | 0 |
_tPloS one _gvol. 7 _gno. 5 _gp. e36476 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0036476 _zAvailable from publisher's website |
| 999 |
_c21770143 _d21770143 |
||